The DOI matches its Crossref record; 225 of the 225 references it cites were found in a registry or an index.
Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
Abstract
Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States. Management of disseminated metastatic CRC involves various active drugs, either in combination or as single agents. The choice of therapy is based on consideration of the goals of therapy, the type and timing of prior therapy, the mutational profile of the tumor, and the differing toxicity profiles of the constituent drugs. This manuscript summarizes the data supporting the systemic therapy options recommended for metastatic CRC in the NCCN Guidelines for Colon Cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–225 of 225
Phase II study of single-agent cetuximab in KRAS G13D mutant metastatic colorectal cancer
Schirripa, M., Loupakis, F., Lonardi, S., Cremolini, C., Bergamo, F., Zagonel, V., & Falcone, A. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv385 · Cited by 32
Wulaningsih, W., Wardhana, A. P., Watkins, J. A., Yoshuantari, N., Repana, D., & Hemelrijck, M. V. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008593.pub3 · Cited by 32
Mur, P., Viana-Errasti, J., García‐Mulero, S., Magraner-Pardo, L., Muñoz, I. G., Pons, T., Capellá, G., Pineda, M., Feliubadaló, L., & Valle, L. (2023) · Genome Medicine · doi:10.1186/s13073-023-01234-y · Cited by 31
Goldstein, D. A., & El‐Rayes, B. F. (2015) · The Oncologist · doi:10.1634/theoncologist.2015-0028 · Cited by 30
Yoshino, T., Uetake, H., Fujita, N., Furuta, T., Katori, J., Hara, N., & Muro, K. (2016) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2016.04.004 · Cited by 30
Meng, L., Thapa, R., Delgado, M., Gómez, M. F. L., Ji, R., Knepper, T. C., Hubbard, J. M., Wang, X., Permuth, J. B., Kim, R. D., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.20035 · Cited by 30
Wu, S., Ma, C.-C., & Li, W. (2015) · Diagnostic Pathology · doi:10.1186/s13000-015-0380-3 · Cited by 29
Rossini, D., Germani, M. M., Lonardi, S., Pietrantonio, F., Dell’Aquila, E., Borelli, B., Allegrini, G., Maddalena, G., Randon, G., Marmorino, F., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.04.019 · Cited by 29
Kopetz, S., Grothey, A. F., Cutsem, E. V., Yaeger, R. D., Wasan, H. S., Yoshino, T., Desai, J., Ciardiello, F., Loupakis, F., Hong, Y. S., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100477 · Cited by 27
on behalf of the ETNA study group., Fourrier‐Réglat, A., Smith, D. M., Rouyer, M., Bénichou, J., Guimbaud, R., Bécouarn, Y., Bernard, O., Noïze, P., Moore, N. D., et al. (2013) · Targeted Oncology · doi:10.1007/s11523-013-0296-3 · Cited by 25
O’Neil, B. H., & Venook, A. P. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.62.8495 · Cited by 22
Self-citationArgilés, G., Mulet-Margalef, N., Valladares‐Ayerbes, M., Viéitez, J. M., Grávalos, C., Alfonso, P. G., Santos, C., Tobeña, M., García-Paredes, B., Benavides, M., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.09.037 · Cited by 22
Patel, A. K., Barghout, V. E., Yenikomshian, M. A., Germain, G., Jacques, P., Laliberté, F., & Duh, M. S. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-0240 · Cited by 21
Zhang, D., Ye, J., Xu, T., & Xiong, B. (2013) · Journal of Chemotherapy · doi:10.1179/1973947813y.0000000070 · Cited by 20
Kagawa, Y., Shinozaki, E., Okude, R., Tone, T., Kunitomi, Y., & Nakashima, M. (2023) · ESMO Open · doi:10.1016/j.esmoop.2023.101614 · Cited by 18
Lv, C., Wu, S., Zheng, D., Wu, Y., Yao, D., & Yu, X. (2013) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2012.1458 · Cited by 17
Zhang, G., Zhou, X., & Lin, C. (2015) · Europe PMC (PubMed Central) · Cited by 17
Cutsem, E. V., Danielewicz, I., Saunders, M. P., Pfeiffer, P., Argilés, G., Borg, C., Glynne‐Jones, R., Punt, C. J. A., van de Wouw, A. J., Fedyanin, M. Y., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01737-2 · Cited by 17
Hurwitz, H. I., & Lyman, G. H. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.7031 · Cited by 16
Vaccaro, G. M., Rothe, M., Mangat, P. K., Garrett-Mayer, E. S., Hwang, J. J., Alese, O. B., Khalil, M. F., Hameed, M. K., Duvivier, H. L., Cannon, T. L., et al. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.2022.40.4_suppl.107 · Cited by 13
Hofheinz, R., Ronellenfitsch, U., Kubicka, S., Falcone, A., Burkholder, I., & Hacker, U. T. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/9189483 · Cited by 12
Managing Advanced Colorectal Cancer: Have We Reached the PEAK With Current Therapies?
Wolpin, B. M., & Bass, A. J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.6316 · Cited by 10
Potemski, P. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.0158 · Cited by 8
Iwamoto, S., Maeda, H., Hazama, S., Oba, K., Okayama, N., Suehiro, Y., Yamasaki, T., Suzuki, N., Nagano, H., Sakamoto, J., et al. (2018) · Journal of Cancer · doi:10.7150/jca.26840 · Cited by 8
Lewis, C. M. (2016) · Clinical journal of oncology nursing · doi:10.1188/16.cjon.319-326 · Cited by 6
Cited by
Anti-EGFR Therapy in Metastatic Colorectal Cancer: Identifying, Tracking, and Overcoming Resistance
Leite, L. F., Noronha, M. M., de Menezes, J. S. A., da Conceição, L. D., Almeida, L. F. C., Cappellaro, A. P., Belotto, M., Biachi de Castria, T., Peixoto, R. D., & Megid, T. B. C. (2025) · Cancers · doi:10.3390/cancers17172804 · Cited by 32
Metadata
- Authors
- Benson, A. B., Venook, A. P., Adam, M., Chang, G., Chen, Y.-J., Ciombor, K. K., Cohen, S. A., Cooper, H. S., Deming, D., Garrido-Laguna, I., Grem, J. L., Haste, P., Hecht, J. R., Hoffe, S., Hunt, S., Hussan, H., Johung, K. L., Joseph, N., Kirilcuk, N., Krishnamurthi, S., Malla, M., Maratt, J. K., Messersmith, W. A., Meyerhardt, J., Miller, E. D., Mulcahy, M. F., Nurkin, S., Overman, M. J., Parikh, A., Patel, H., Pedersen, K., Saltz, L., Schneider, C., Shibata, D., Shogan, B., Skibber, J. M., Sofocleous, C. T., Tavakkoli, A., Willett, C. G., Wu, C., Gurski, L. A., Snedeker, J., & Jones, F.
- Venue
- Journal of the National Comprehensive Cancer Network
- Publisher
- Harborside Press, LLC
- Published
- 2024-06
- Volume
- 22
- Issue
- 2D
- ISSN
- 1540-1405 (ISSN-L)
- 1540-1413
- OpenAlex
- W4399521812
- Cited by
- 371
- References
- 225
- FWCI
- 56.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.